5Yuki, Hayashi N, Katayama K, et al. Quantitative analysis of PreS1 and PreS2 in relation to HBsAg expression [J]. Hepatology, 1990,11(1):38.
6Petit MA, Zoulin F, Capel F, et al. Variable expression of PreS1 antigen in serum dering chronic hepatitis B virus infection: an accurate maker for the level of hepatitis B virus replication[J]. Hepatology, 1990,11 ( 12): 809.
二级参考文献19
1Zoulim F,Capel F, Berthillon P, et al. Clinical and virological evaluation of the detection of pre S1 and pre S2 antigens in serum from patients with chronic hepatitis B [ J]. Gastroenterol Clin Biol, 1995, 19(12) :970.
2Alberti A, Cavalletto D, Chemello L, et al. Fine spesificity of human antibody response to the domain of hepatitis B vim[J]. Hepatology,1990,12(2) : 199.
3Klinkert MQ,Theilmann L,Pfaff E, et al. Pre S1 antigens and antibodies early in the course of acute hepatitis B virus infection[ J] .J Virol,1986,58(2) :522.
4Theilmann L, Klinkert MQ, Gmelin K, et al. Detection of Pie S1 proteins in serum and liver of HBsAg-positive patients: A new marker for hepatitis B virus infection[J]. Hepatology, 1986,6(2):186.
5Delaro C,Colloca S,Tailiani G, et al. Clearance of hepatitis B virus,DNA and pre S surface antigens in patients with markers of acute viral replication[ J ]. J Med Virol, 1989,28 (2) : 169.
6Petit MA,Zoulim F, Capel F,et al. Variable expression of Pre S1 antigen in serum during chronic hepatitis B Virus infectiun: An accuratemarker for the level of hepatitis B Virus replication [ J ]. Hepatology,1990,11(12) :809.
7Yuki N, Hayashi N, Katayama K, et al. Quantitative analysis of Pre Sl and pre S2 in relation to HBsAg expression[J]. Hepatology, 1990, 11(1) :38.
8Molachlan A, Molecular biology of the hepatitis B Virus l M ]. First ed-Boston: CRC Press, 1991.112.
9Dash S, Rao KV, Panda SK. Receptor for Pro S1 (21-47)component of hepatitis B Virus on the livex cell: role in virus cell interaction[ J]. J Med Virol, 1992,37(3) : 16-21.
10Gerken G, Paterlini P, Manns M, et al. Assay of hepatitis B virus DNA by polymerase chain reaction and its relationship to pre S and S-encodrd viral surface antigen[J]. Hepatology, 1991,13(2) : 158.
1Jing You Lin Zhuang Bao Zhang Tang Wei Bo Yang Su Ying Ding Wu Li Rong Xue Wu Hong Li Zhang Yan Mei Zhang Shao Ming Yan Lu Zhang ~1Department of Infectious Diseases,The First Affiliated Hospital of Kunming Medical College,Kunming 650032,Yunnan Province,China ~2Departrnent of Hepatology,Kunming Third Municipal People’s Hospital,Kunming 650041,Yunnan Province,China.A randomized controlled clinical trial on the treatment of Thymosin-a1 versus interferon-α in patients with hepatitis B[J].World Journal of Gastroenterology,2001,7(3):411-414. 被引量：47
4Pichoud C,Berby F, Stuyver L, et al. Persistence of viral replication after anti-HBe seroconversion during antiviral therapy for chronic hepatitis B [J].J Hepatol, 2000,32(2):307-316.
5Ikeda K, Arose Y, Saitoh S, et al. Long term outcome of HBV carriers with negative HBe antigen and normal aminotransferase [J]. Am J Med, 2006,119(11): 977-985.
6Funk ML,Rosenberg DM,Lok AS.World-wide epidemiology ofHBeAg-negative chronic hepatitis B and associated percore and core promomr variants[J].J V'Lral Hepat, 2002,9(1):52-61.
7Pichoud C,Berby F,Stuyver L,et al.Persistence of viral replication after anti-Hbe seroconversion during antiviral therapy for chronic hepatitis B[J].Journal of Hepatology,2000; 32 (2):307-316.
8Ikeda K,Arase Y,Saitoh S,et al.Long term outcome of HBV carriers with negative HBe antigen and normal aminotransferase[J].Am J Med.2006; 119(11):977-985.
9Funk ML,Rosenberg DM,Lok AS.World-wide epidemiology of HBeAg-negative chronic hepatitis B and associated precore and core promomr variants[J].J Viral Hepat.2002;9(1):52-61.
